Product Information
CLOBETASOL 0.05% SOLUTION is a generic product labeled by Macleods Pharmaceuticals Limited, priced at $0.1359 per ML under NDC 33342032186. Its NADAC has been published 434 times since Jun 13, 2018.
FDA first approved this application on Oct 25, 2017. Its Orange Book therapeutic-equivalence code is AT.
Strength
.4625 mg/mL
Manufacturer
Macleods Pharmaceuticals LimitedNDC
33342032186
Classification
Generic
Dosage Form
SOLUTION
Route
TOPICAL
Effective Date
9/23/2026
Active Ingredients
CLOBETASOL PROPIONATEApproval Type
Generic (ANDA)
FDA Application
ANDA209361FDA Approved
10/25/2017
TE Code
AT
On Market Since
11/4/2017
Pharmacological Classes
Price Statistics
The NADAC for CLOBETASOL 0.05% SOLUTION has been published 434 times since Jun 13, 2018, and over the history we have for it it has declined 85.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1359 per ML |
|---|---|
| All-time high | $0.9484 (Jun 13, 2018) |
| All-time low | $0.1149 (May 20, 2026) |
| 52-week high | $0.1829 |
| 52-week low | $0.1149 |
| Median price | $0.3248 |
| Average price | $0.3881 |
| Largest weekly change | +42.8% (Feb 22, 2023) |
| Weeks tracked | 434 |
| Tracking since | Jun 13, 2018 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Clobetasol Propionate market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Macleods Pharmaceuticals Limited manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Clobetasol Propionate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Corticosteroid class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of CLOBETASOL 0.05% SOLUTION?
The current National Average Drug Acquisition Cost (NADAC) for CLOBETASOL 0.05% SOLUTION, manufactured by Macleods Pharmaceuticals Limited, is $0.1359 per ML (NDC 33342032186), effective Sep 30, 2026.
How has the price of CLOBETASOL 0.05% SOLUTION changed over time?
Over the history we have for it, the NADAC for CLOBETASOL 0.05% SOLUTION has declined 85.7%. It has been tracked across 434 weekly CMS publications since Jun 13, 2018.
What are the highest and lowest recorded NADAC prices for CLOBETASOL 0.05% SOLUTION?
Since Jun 13, 2018, the NADAC for CLOBETASOL 0.05% SOLUTION has ranged from a low of $0.1149 (May 20, 2026) to a high of $0.9484 (Jun 13, 2018), with a median of $0.3248 per ML.
Are there cheaper alternatives to CLOBETASOL 0.05% SOLUTION?
No other NADAC-published product currently shares the active ingredient and strength of CLOBETASOL 0.05% SOLUTION in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures CLOBETASOL 0.05% SOLUTION?
CLOBETASOL 0.05% SOLUTION (NDC 33342032186) is labeled by Macleods Pharmaceuticals Limited, and CMS classifies it as a generic product.